HPV Vaccination Drive in Kozhikode: Key Facts for UPSC & State PCS

13 Oct HPV Vaccination Drive in Kozhikode: Key Facts for UPSC & State PCS

✎ HPV vaccination in India is a preventive oncology measure under the UIP, targeting girls aged 9–14 years to reduce cervical cancer burden, with Kerala’s Kozhikode district achieving 51% coverage in a recent drive.

Subject Relevance — Where This Topic Fits

• GS Paper II — Governance, Transparency and Accountability  |  GS Paper III — Science and Technology (Health Sector)
• Prelims: Human Papilloma Virus (HPV), Cervical Cancer, Universal Immunisation Programme (UIP), Mission Indradhanush, National Technical Advisory Group on Immunisation (NTAGI), Vaccine Preventable Diseases (VPD), Kerala State Health Mission
• Essay: The Role of Public Health Initiatives in Reducing Disease Burden, Science, Technology, and Governance: Bridging Gaps in Health Delivery

Quick Revision: HPV vaccination in India is a preventive oncology measure under the UIP, targeting girls aged 9–14 years to reduce cervical cancer burden, with Kerala’s Kozhikode district achieving 51% coverage in a recent drive.

Why is this in the news?

The successful administration of the HPV vaccine to 13,505 girls aged up to 14 in Kozhikode district, Kerala, represents a significant milestone in India’s public health strategy to combat cervical cancer, a leading cause of mortality among women in low- and middle-income countries. The drive, covering 51% of the target demographic, underscores the operational challenges and policy interventions required for large-scale immunisation campaigns in India’s decentralised health system.

Background

• Cervical cancer is the fourth most common cancer among women globally, with India accounting for approximately 123,907 new cases and 77,348 deaths annually, as per the International Agency for Research on Cancer (IARC) estimates.
• The Human Papilloma Virus (HPV) is the primary etiological agent for cervical cancer, with high-risk types (e.g., HPV 16 and 18) responsible for over 70% of cases.
• India’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) includes cervical cancer screening and HPV vaccination as key components.
• Kerala, a high-performing state in health indicators, has adopted a phased approach to HPV vaccination, aligning with the National Health Mission’s (NHM) guidelines.
• Mission Indradhanush, launched in 2014, aims to achieve 90% full immunisation coverage through targeted drives, including for HPV.

What is the HPV Vaccination Programme?

• The HPV Vaccination Programme is a public health initiative under the Universal Immunisation Programme (UIP), targeting girls aged 9–14 years to prevent cervical cancer by vaccinating against high-risk HPV strains.
• The Government of India, in collaboration with state health departments, conducts phased rollouts, with Kerala being one of the early adopters.
• The vaccine is provided free of cost at government health centres, schools, and outreach sessions, ensuring equitable access.
• The programme is guided by the National Technical Advisory Group on Immunisation (NTAGI), which recommends scientific and technical protocols.
• Monitoring and evaluation are conducted through the Health Management Information System (HMIS) and periodic coverage assessments.
• The initiative aligns with the World Health Organization’s (WHO) global strategy to eliminate cervical cancer by 2030, aiming for 90% vaccination coverage among girls by age 15.
• Community engagement, awareness campaigns, and school-based vaccination drives are critical components of the programme’s implementation.

Key Features

Feature	Significance
Target Population: Girls aged up to 14 years	Ensures immunisation coverage during the most critical window for HPV prevention, aligning with the World Health Organization’s recommendation for vaccination before sexual debut.
Coverage Rate: 51% of target achieved	Demonstrates partial but substantial progress in public health intervention, highlighting the need for sustained outreach to achieve universal coverage.
School-Based Vaccination: 1,854 girls vaccinated in 169 schools	Leverages existing institutional infrastructure to enhance accessibility, reduce absenteeism, and normalise preventive healthcare among adolescents.
Extended Deadline: Until December 31, 2026	Provides additional time for districts lagging in coverage to intensify efforts, ensuring equitable access across regions.
Government Health Centre Availability	Ensures last-mile delivery of vaccines, reducing barriers related to cost, distance, and awareness, particularly in rural and underserved areas.

Why it Matters

Public Health Impact

• HPV vaccination significantly reduces the incidence of cervical cancer, the fourth most common cancer among women globally, with over 95% efficacy when administered before exposure to the virus.
• Prevents transmission of HPV, thereby lowering the burden of related diseases, including genital warts and certain oropharyngeal cancers.
• Aligns with India’s commitment to Sustainable Development Goal 3 (Good Health and Well-being), particularly Target 3.7 on universal access to sexual and reproductive healthcare services.

Policy and Governance

• Illustrates the operationalisation of the National Health Mission (NHM) and the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), which include HPV vaccination as a key component.
• Demonstrates the role of district-level health authorities in executing centrally sponsored schemes, ensuring localised implementation and monitoring.
• Highlights the importance of inter-sectoral coordination between health departments, education departments, and local governance bodies for successful public health campaigns.

Socio-Economic Dimensions

• Reduces long-term healthcare costs by preventing HPV-related diseases, which impose a substantial economic burden on families and the healthcare system.
• Promotes gender equity in health by prioritising adolescent girls, a demographic often marginalised in preventive healthcare interventions.
• Enhances human capital development by safeguarding the health of future generations, contributing to improved workforce productivity and economic growth.

Global Health Alignment

• Supports the World Health Organization’s global strategy to eliminate cervical cancer as a public health problem by 2030, targeting a 90% vaccination coverage rate for girls by age 15.
• Contributes to achieving the Global Strategy for Women’s, Children’s, and Adolescents’ Health (2016–2030), which includes immunisation as a critical intervention.
• Demonstrates India’s adherence to international health commitments, reinforcing its role in global health diplomacy and cooperation.

Challenges

1. Vaccine Hesitancy and Misinformation

• Public scepticism regarding vaccine safety, efficacy, or necessity may impede uptake, particularly in communities with low health literacy or exposure to anti-vaccination narratives.
• Misconceptions about HPV transmission or the vaccine’s association with sexual behaviour can deter participation, necessitating targeted awareness campaigns.

UPSC Link: GS2: Health, GS3: Science & Technology

2. Logistical and Infrastructure Constraints

• Ensuring a consistent cold chain supply for vaccines across remote or underserved areas remains a challenge, particularly in districts with inadequate healthcare infrastructure.
• Coordinating school-based vaccination drives with academic schedules and parental consent requirements can be logistically complex.

UPSC Link: GS2: Governance, GS3: Infrastructure

3. Equity Gaps in Coverage

• Disparities in vaccination rates may emerge between urban and rural areas, or among socio-economic groups, due to differential access to healthcare services and information.
• Marginalised communities, including tribal populations or those with limited digital literacy, may face barriers to awareness or participation.

UPSC Link: GS1: Social Justice, GS2: Welfare Schemes

4. Monitoring and Evaluation

• Tracking vaccination coverage and ensuring follow-up doses for multi-dose vaccines require robust data systems, which may be underdeveloped in some regions.
• Assessing the impact of the campaign on disease incidence necessitates long-term surveillance, posing challenges for immediate evaluation.

UPSC Link: GS2: Health, GS3: Data Governance

5. Resource Allocation and Sustainability

• Sustaining high vaccination coverage requires consistent funding, which may compete with other health priorities in resource-constrained settings.
• Ensuring vaccine procurement and distribution at scale demands robust supply chain management and inter-departmental coordination.

UPSC Link: GS2: Public Finance, GS3: Economic Development

Challenges — UPSC Perspective

Issue	Concern
Vaccine Hesitancy	Public reluctance due to misinformation or cultural beliefs may reduce participation rates.
Cold Chain Management	Maintaining vaccine potency in transit and storage, especially in rural areas, is critical.
Parental Consent	Obtaining informed consent from guardians for minors may delay or limit vaccination.
School Coordination	Aligning vaccination drives with academic calendars requires meticulous planning.
Data Tracking	Accurate record-keeping and follow-up for multi-dose schedules is essential but challenging.
Equity Gaps	Ensuring uniform coverage across socio-economic and geographic divides remains a persistent issue.

Government Initiatives — Must-Memorise for Prelims

• National Health Mission (NHM)
• National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)

Way Forward

• Intensify community engagement through local leaders, healthcare workers, and school authorities to address vaccine hesitancy and misinformation.
• Strengthen cold chain infrastructure in underserved areas to ensure vaccine potency during storage and transportation.
• Leverage digital platforms (e.g., Aarogya Setu, UMANG) to disseminate accurate information and facilitate parental consent.
• Conduct micro-planning at the district level to identify high-risk or low-coverage areas and tailor interventions accordingly.
• Enhance multi-sectoral coordination between health, education, and local governance bodies to streamline school-based vaccination drives.
• Invest in robust data systems for real-time tracking of vaccination coverage and adverse events, ensuring transparency and accountability.
• Allocate dedicated funds for procurement, distribution, and monitoring to sustain the campaign beyond the extended deadline.
• Collaborate with non-governmental organisations (NGOs) and civil society groups to enhance grassroots outreach and trust-building.

UPSC Value Addition

Prelims Practice Questions

Q1. Consider the following statements regarding the Human Papillomavirus (HPV) vaccine in India:
1. The HPV vaccine is part of the Universal Immunization Programme (UIP) in India.
2. The National Technical Advisory Group on Immunization (NTAGI) recommends the inclusion of HPV vaccine in the UIP.
3. The HPV vaccine is administered in a single dose for all eligible individuals.
4. The Government of India has launched a dedicated mission, Mission Indradhanush, to improve HPV vaccination coverage.

How many of the above statements are correct?

1. Only one
2. Only two
3. Only three
4. All

Answer: Only three — Statements 1 and 2 are correct. The HPV vaccine was introduced in the UIP in 2023 on the recommendation of NTAGI. Statement 3 is incorrect as the HPV vaccine is administered in a two-dose schedule for girls aged 9–14 years. Statement 4 is incorrect as Mission Indradhanush focuses on improving routine immunization coverage for all vaccines, not HPV specifically.

Q2. Assertion (A): The HPV vaccine is primarily targeted at preventing cervical cancer in women.
Reason (R): The HPV vaccine protects against all strains of the Human Papillomavirus, including those not linked to cervical cancer.

1. Both A and R are true, and R is the correct explanation of A
2. Both A and R are true, but R is NOT the correct explanation of A
3. A is true, but R is false
4. A is false, but R is true

Answer: A is false, but R is true — Assertion (A) is true as the HPV vaccine is primarily targeted at preventing cervical cancer. Reason (R) is false because the HPV vaccine does not protect against all strains of HPV; it targets the most oncogenic strains (e.g., HPV 16 and 18) responsible for the majority of cervical cancer cases.

Q3. Match the following vaccines with their respective target diseases:

Column I (Vaccine) | Column II (Target Disease)
——————-|———————–
A. HPV Vaccine | 1. Tuberculosis
B. BCG Vaccine | 2. Diphtheria, Tetanus, Pertussis
C. Pentavalent Vaccine | 3. Cervical Cancer
D. Rotavirus Vaccine | 4. Rotaviral Diarrhea

Select the correct match:

1. A-3, B-1, C-2, D-4
2. A-1, B-3, C-2, D-4
3. A-2, B-1, C-3, D-4
4. A-3, B-4, C-2, D-1

Answer: A-3, B-1, C-2, D-4 — The correct matches are: HPV Vaccine (A) targets Cervical Cancer (3), BCG Vaccine (B) targets Tuberculosis (1), Pentavalent Vaccine (C) targets Diphtheria, Tetanus, and Pertussis (2), and Rotavirus Vaccine (D) targets Rotaviral Diarrhea (4).

Mains Practice Question

✍ The introduction of the Human Papillomavirus (HPV) vaccine into India’s Universal Immunization Programme (UIP) represents a significant public health intervention. Critically examine the policy, implementation challenges, and socio-cultural determinants influencing HPV vaccination coverage in India. Also, assess the role of state-level initiatives, such as the Kerala model, in enhancing immunization outcomes. (15 Marks)

Approach: A full answer must cover the following dimensions:

1. **Policy Context and Rationale**:
– Brief on the inclusion of HPV vaccine in UIP (2023) and its justification (cervical cancer burden: ~1.23 lakh cases/year, 77,000 deaths; HPV strains 16/18 cause ~70% of cases).
– Role of NTAGI and WHO recommendations.

2. **Implementation Framework**:
– Target population: girls aged 9–14 years (two-dose schedule).
– Delivery mechanisms: schools, government health centres, and Anganwadi centres.
– Integration with Mission Indradhanush and Intensified Mission Indradhanush.

3. **Challenges**:
– **Vaccine hesitancy**: Myths (e.g., infertility, promiscuity), lack of awareness, and misinformation.
– **Logistical barriers**: Cold chain management, last-mile delivery in rural areas.
– **Socio-cultural factors**: Gender norms, parental consent, stigma around sexually transmitted infections.
– **Monitoring and evaluation**: Data gaps, AEFI (Adverse Events Following Immunization) reporting.

4. **Kerala Model of Public Health Governance**:
– Decentralized planning (Panchayati Raj Institutions), ASHA workers, and community engagement.
– High literacy and health awareness as facilitators.
– Role of District Medical Officers (DMOs) in micro-planning and real-time monitoring.

5. **Comparative Perspective**:
– Contrast with global best practices (e.g., Australia’s 90% coverage, Rwanda’s school-based delivery).

6. **Way Forward**:
– Multi-stakeholder collaboration (health, education, and women and child development departments).
– Community awareness campaigns (e.g., IEC materials, celebrity endorsements).
– Strengthening AEFI surveillance and adverse event reporting systems.
– Addressing equity: coverage gaps in tribal and migrant populations.

Source: The Hindu

Kerala PCS (Kerala PSC (KAS)) — State PCS Practice

Prelims: As part of the Kerala Government’s initiative to combat cervical cancer, the HPV vaccination drive in Kozhikode district has covered 13,505 girls. Under which scheme was this vaccination drive conducted?

1. A. Arogya Keralam Mission
2. B. Jeevani Health Programme
3. C. Nava Kerala Mission
4. D. Haritha Keralam Mission

Answer: B. Jeevani Health Programme — The HPV vaccination drive in Kozhikode was conducted under the Jeevani Health Programme, which focuses on adolescent health and immunization.

Mains: Discuss the significance of the HPV vaccination drive in Kozhikode district for public health in Kerala. Examine the role of government schemes like Jeevani Health Programme in achieving universal immunization goals.

---

Generated by AanyaAi for educational purpose.

---

Related guides on our sites

• Current affairs for upsc 2026
• How to prepare for GS paper 1 for UPSC CSE mains exam
• Best UPSC coaching for IFOS exam
• Best mentorship programme for upsc